BML-190
BML-190, also known as IMMA and LM-4131 or Indomethacin Morpholinylamide, is selective CB2 receptor agonist. The binding constant for the CB2 receptor is 435 nM compared to >20,000 nM for the cannabinoid receptor, CB1. BML-190 reduces the basal levels of inositol phosphate production in cells expressing the CB (2) receptor and 16z44. BML-190 acts as inverse agonist at the human CB (2) receptor acting via G alpha (i/o) and G alpha (q) family-coupled pathways.
Product Specifications
CAS Number
2854-32-2
Product Name Alternative
BML-190 | BML 190 | BML190 | Indomethacin Morpholinylamide.
Purity
>98% (HPLC)
Solubility
DMSO : 50 mg/mL 117.13 mM
Smiles
Cc1c (c2c (n1C (=O) c1ccc (cc1) Cl) ccc (c2) OC) CC (=O) N1CCOCC1
Molecular Formula
C23H23ClN2O4
Molecular Weight
426.89
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
2-[1- (4-chlorobenzoyl) -5-methoxy-2-methyl-1H-indol-3-yl]-1- (4-morpholinyl) -ethanone
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Charcot Leyden Crystal Protein CLIA Kit
